About the Bone Sarcoma Session
Bone sarcoma, a rare form of cancer originating in bone tissue, presents diverse subtypes like osteosarcoma, Ewing sarcoma, and chondrosarcoma, each demanding unique treatment strategies. In cancer research, emphasis lies on unraveling genetic mutations and molecular pathways propelling bone sarcoma progression. Modern tools such as genomic sequencing and molecular profiling aid in pinpointing potential therapeutic targets, paving the way for personalized treatment avenues. Ongoing clinical trials explore innovative drugs and immunotherapies, promising enhanced outcomes for patients grappling with bone sarcoma. A collaborative approach among researchers, clinicians, and patients plays a pivotal role in advancing our comprehension of this intricate disease and fostering more efficacious treatment modalities.
Topics Covered in Bone Sarcoma
Osteosarcoma
Chondrosarcoma
Small Round Cell Tumors
Chordoma
Neoadjuvant Chemotherapy
Pulmonary Metastases
Related Scientific Sessions at CIOC 2027
Why Attend the Bone Sarcoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Bone Sarcoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Bone Sarcoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Bone Sarcoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Bone Sarcoma Conference 2027 — FAQs
What is the Bone Sarcoma track at CIOC 2027?
The Bone Sarcoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Bone Sarcoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Bone Sarcoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Bone Sarcoma are all welcome — whether presenting or attending.
Can I present my research in the Bone Sarcoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Bone Sarcoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Bone Sarcoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.